{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:17:13Z","timestamp":1784546233083,"version":"3.55.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.clinthera.2022.10.003","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T17:52:11Z","timestamp":1668793931000},"page":"e39-e58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Systematic Review of Medical Cannabinoids Dosing in Human"],"prefix":"10.1016","volume":"44","author":[{"given":"David A.","family":"Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar J.","family":"Mendivil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam E.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2022.10.003_bib0001","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/bcp.13710","article-title":"The pharmacokinetics and the pharmacodynamics of cannabinoids","volume":"84","author":"Lucas","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0002","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.7150\/ijms.27087","article-title":"Cannabinoids: From pot to lab","volume":"15","author":"Papaseit","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0003","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0004","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1063545","article-title":"Neuroscience: Endocannabinoid signaling in the brain","volume":"296","author":"Wilson","year":"2002","journal-title":"Science (80-.)"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0005","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0006","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0007","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","article-title":"Practical considerations in medical cannabis administration and dosing","volume":"49","author":"MacCallum","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0008","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J175v02n03_02","article-title":"Cannabis treatments in obstetrics and gynecology: A historical review","volume":"2","author":"Russo","year":"2002","journal-title":"J. Cannabis Ther."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0009","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.08.014","article-title":"Cannabis use during pregnancy: Pharmacokinetics and effects on child development","volume":"182","author":"Grant","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0010","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0011","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cpdd.36","article-title":"A multiple-dose, randomized, double-blind, placebo-controlled, parallel-group QT\/QTc study to evaluate the electrophysiologic effects of THC\/CBD spray","volume":"2","author":"Sellers","year":"2013","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0012","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/14740338.2017.1397128","article-title":"Drug-drug interactions as a result of co-administering \u03949-THC and CBD with other psychotropic agents","volume":"17","author":"Rong","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00003495-198530020-00002","article-title":"Nabilone: A Preliminary Review of its Pharmacological Properties and Therapeutic Use","volume":"30","author":"Ward","year":"1985","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0014","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00280-017-3387-5","article-title":"A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics","volume":"80","author":"Badowski","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0015","unstructured":"Cannabidiol (CBD) Critical Review Report Expert Committee on Drug Dependence Fortieth Meeting Geneva, 4-7 June 2018. https:\/\/www.who.int\/docs\/default-source\/controlled-substances\/whocbdreportmay2018-2.pdf?sfvrsn=f78db177_2&download=true."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0016","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/can.2016.0034","article-title":"An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies","volume":"2","author":"Iffland","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0017","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/03602532.2013.849268","article-title":"Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: A systematic review","volume":"46","author":"Stout","year":"2014","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0018","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.lfs.2011.05.018","article-title":"Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes","volume":"89","author":"Jiang","year":"2011","journal-title":"Life Sci"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0019","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/epi.13060","article-title":"Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy","volume":"56","author":"Geffrey","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2018.07.029","article-title":"Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues behavioural alterations and brain atrophy in a mouse model of Rett syndrome","volume":"140","author":"Vigli","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0021","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.bjp.0707124","article-title":"The psychoactive plant cannabinoid, \u0394 9- tetrahydrocannabinol, is antagonized by \u0394 8- and \u0394 9-tetrahydrocannabivarin in mice in vivo","volume":"150","author":"Pertwee","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0022","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0023","first-page":"103","article-title":"Molecular Targets of the Phytocannabinoids: A Complex Picture","volume":"103","author":"Morales","year":"2017","journal-title":"Prog. Chem. Org. Nat. Prod."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0024","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11101-008-9094-4","article-title":"Secondary metabolism in cannabis","volume":"7","author":"Flores-Sanchez","year":"2008","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0025","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3732\/ajb.91.6.966","article-title":"A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae","volume":"91","author":"Hillig","year":"2004","journal-title":"Am. J. Bot."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0026","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drugalcdep.2017.08.010","article-title":"Physicians-in-training are not prepared to prescribe medical marijuana","volume":"180","author":"Evanoff","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0027","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMra1614394","article-title":"Evidence for Health Decision Making \u2014 Beyond Randomized, Controlled Trials","volume":"377","author":"Frieden","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0028","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1186\/1471-2458-12-439","article-title":"The weight of nations: An estimation of adult human biomass","volume":"12","author":"Walpole","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0029","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jagp.2015.07.011","article-title":"Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial","volume":"23","author":"Van Den Elsen","year":"2015","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/0269881116665357","article-title":"Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial","volume":"31","author":"Van Den Elsen","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0031","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000498924","article-title":"Prescription of a THC\/CBD-Based Medication to Patients with Dementia: A Pilot Study in Geneva","volume":"2","author":"Broers","year":"2019","journal-title":"Med. Cannabis Cannabinoids"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0032","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/eat.22804","article-title":"The effect of dronabinol in a male patient with anorexia nervosa suffering from severe acute urge to be physically active","volume":"51","author":"Graap","year":"2018","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0033","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.bbmt.2015.05.018","article-title":"Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study","volume":"21","author":"Yeshurun","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0034","first-page":"3029","article-title":"The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial","volume":"26","author":"Turcott","year":"2018","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/0003489415612801","article-title":"Improving quality of life with nabilone during radiotherapy treatments for head and neck cancers: A randomized double-blind placebo-controlled trial","volume":"125","author":"C\u00f4t\u00e9","year":"2016","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0036","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/2049463717710042","article-title":"Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies","volume":"11","author":"Fallon","year":"2017","journal-title":"Br. J. Pain"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0037","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jpainsymman.2017.09.001","article-title":"Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain","volume":"55","author":"Lichtman","year":"2018","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0038","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.drugalcdep.2016.02.020","article-title":"Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings","volume":"161","author":"Trigo","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0039","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/ADM.0000000000000229","article-title":"Sativex associated with behavioral-relapse prevention strategy as treatment for cannabis dependence: A case series","volume":"10","author":"Trigo","year":"2016","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0040","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1007\/s00213-016-4298-6","article-title":"Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users","volume":"233","author":"Herrmann","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0041","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.drugalcdep.2015.11.025","article-title":"Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial","volume":"159","author":"Levin","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0042","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/ajad.12622","article-title":"Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study","volume":"26","author":"Hill","year":"2017","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0190768","article-title":"Nabiximols combined with motivational enhancement\/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial","volume":"13","author":"Trigo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0044","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cgh.2016.09.147","article-title":"Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study","volume":"15","author":"de Vries","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0045","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s10620-017-4540-z","article-title":"Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial","volume":"62","author":"Naftali","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0046","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2337\/dc16-0650","article-title":"Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel group pilot study","volume":"39","author":"Jadoon","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0047","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0048","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamaneurol.2020.0073","article-title":"Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial","volume":"77","author":"Miller","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0049","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/0883073816669450","article-title":"Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases","volume":"32","author":"Gofshteyn","year":"2017","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0050","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/epi.13499","article-title":"Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex","volume":"57","author":"Hess","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0051","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0052","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1111\/epi.13815","article-title":"Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol","volume":"58","author":"Rosenberg","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0053","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/13554794.2017.1391294","article-title":"The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy","volume":"23","author":"Warren","year":"2017","journal-title":"Neurocase"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0054","unstructured":"ClinicalTrials.gov, \u201cStudy to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver Disease - Full Text View - ClinicalTrials.gov.\u201d https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01284634 (accessed Mar. 05, 2021)."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0055","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1007\/s00415-016-8145-9","article-title":"A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease","volume":"263","author":"L\u00f3pez-Send\u00f3n Moreno","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0056","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ibd\/izy002","article-title":"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis","volume":"24","author":"Irving","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0057","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0058","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of Cannabidiol on Drop Seizures in the Lennox\u2013Gastaut Syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0059","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.clinthera.2015.07.023","article-title":"A 4-week Pilot Study with the Cannabinoid Receptor Agonist Dronabinol and Its Effect on Metabolic Parameters in a Randomized Trial","volume":"37","author":"Reichenbach","year":"2015","journal-title":"Clin. Ther."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/pme.12569","article-title":"Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: A randomized controlled trial","volume":"16","author":"Turcotte","year":"2015","journal-title":"Pain Med. (United States)"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0061","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/ane.12660","article-title":"Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex\u00ae","volume":"135","author":"Carotenuto","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0062","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.clinthera.2017.01.016","article-title":"Effects on Spasticity and Neuropathic Pain of an Oral Formulation of \u03949-tetrahydrocannabinol in Patients With Progressive Multiple Sclerosis","volume":"40","author":"van Amerongen","year":"2018","journal-title":"Clin. Ther."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0063","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/WNF.0000000000000294","article-title":"Tetrahydrocannabinol\/Cannabidiol Oromucosal Spray in Patients with Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship","volume":"41","author":"Contin","year":"2018","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0064","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000481089","article-title":"Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients","volume":"78","author":"Schimrigk","year":"2017","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0065","first-page":"1","article-title":"Dronabinol increases pain threshold in patients with functional chest pain: A pilot double-blind placebo-controlled trial","volume":"30","author":"Malik","year":"2017","journal-title":"Dis. Esophagus"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0066","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsx184","article-title":"Pharmacotherapy of apnea by cannabimimetic enhancement, the PACE clinical trial: Effects of dronabinol in obstructive sleep apnea","volume":"41","author":"Carley","year":"2018","journal-title":"Sleep"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0067","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugalcdep.2015.05.013","article-title":"The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone","volume":"154","author":"Bisaga","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0068","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.drugalcdep.2015.09.031","article-title":"Safety of oral dronabinol during opioid withdrawal in humans","volume":"157","author":"Jicha","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0069","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.drugalcdep.2016.05.002","article-title":"Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans","volume":"164","author":"Lofwall","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0070","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/bcp.12811","article-title":"Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: Analgesic efficacy, pharmacokinetics and tolerability","volume":"81","author":"De Vries","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0071","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psyneuen.2014.11.002","article-title":"The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study","volume":"51","author":"Jetly","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0072","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7812\/TPP\/16-005","article-title":"Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report","volume":"20","author":"Shannon","year":"2016","journal-title":"Perm. J."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0073","first-page":"385","article-title":"Une \u00e9tude randomis\u00e9e contr\u00f4l\u00e9e pour \u00e9valuer l'efficacit\u00e9 du nabilone pour la pr\u00e9vention des naus\u00e9es et vomissements postop\u00e9ratoires aigus lors de chirurgie non urgente,\u201d Can","volume":"64","author":"Levin","year":"2017","journal-title":"J. Anesth."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0074","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-019-1024-y","article-title":"Nabilone administration in refractory chronic diarrhea: A case series","volume":"19","author":"Pellesi","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: A multicenter randomized controlled trial","volume":"175","author":"McGuire","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0076","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00213-018-4885-9","article-title":"The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial","volume":"235","author":"Boggs","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0077","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0883073818773028","article-title":"Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders","volume":"33","author":"Libzon","year":"2018","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0078","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.pediatrneurol.2015.02.008","article-title":"Pure Cannabidiol in the Treatment of Malignant Migrating Partial Seizures in Infancy: A Case Report","volume":"52","author":"Saade","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0079","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pediatrneurol.2017.02.009","article-title":"Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome","volume":"71","author":"Kaplan","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0080","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/add.14243","article-title":"Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal","volume":"113","author":"Hindocha","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0081","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/1039856216663737","article-title":"Severe motor and vocal tics controlled with Sativex\u00ae","volume":"24","author":"Trainor","year":"2016","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0082","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/0091217418791455","article-title":"Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report","volume":"54","author":"Pichler","year":"2019","journal-title":"Int. J. Psychiatry Med."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0083","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yebeh.2018.07.020","article-title":"Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study","volume":"87","author":"Szaflarski","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0084","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/epi.13852","article-title":"Interactions between cannabidiol and commonly used antiepileptic drugs","volume":"58","author":"Gaston","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0085","unstructured":"ClinicalTrials.gov, \u201cCannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD) - Full Text View - ClinicalTrials.gov.\u201d https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03202303 (accessed Mar. 05, 2021)."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0086","unstructured":"ClinicalTrials.gov, \u201cEffects of Cannabidiol in Alcohol Use Disorder - Full Text View - ClinicalTrials.gov.\u201d https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03252756 (accessed Mar. 05, 2021)."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0087","unstructured":"ClinicalTrials.gov, \u201cCannabidiol and Cocaine Craving\/Dependence - Full Text View - ClinicalTrials.gov.\u201d https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02559167 (accessed Mar. 05, 2021)."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0088","series-title":"The Cannabis Health Index_ Combining the Science of Medical Marijuana with Mindfulness Techniques To Heal 100 Chronic Symptoms and Diseases","author":"Blesching","year":"2015"},{"key":"10.1016\/j.clinthera.2022.10.003_bib0089","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1389200217666151210142051","article-title":"Cannabinoids and Cytochrome P450 Interactions","volume":"17","author":"Zendulka","year":"2016","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.clinthera.2022.10.003_bib0090","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/can.2016.0009","article-title":"Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes","volume":"1","author":"Russo","year":"2016","journal-title":"Cannabis Cannabinoid Res"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291822003496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291822003496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:58:51Z","timestamp":1758963531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291822003496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":90,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0149291822003496"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2022.10.003","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Systematic Review of Medical Cannabinoids Dosing in Human","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2022.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}